home / stock / eyes / eyes news

EYES News and Press, Second Sight Medical Products Inc. From 03/13/19

Stock Information
Company Name: Second Sight Medical Products Inc.
Stock Symbol: EYES
Market: NASDAQ
Menu
EYES EYES Quote EYES Short EYES News EYES Articles EYES Message Board
Get EYES Alerts

News, Short Squeeze, Breakout and More Instantly...
EYES - Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today reported fin...
EYES - Second Sight to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 Conference Call

Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, will release its 2018 fourth quarter and year-end financial results on Wednesday, Mar...

EYES - Second Sight Medical Products, Inc. Announces Completion of Rights Offering

Expiration date of all outstanding warrants listed for trading under the “EYESW” symbol is extended to 5:00 p.m. New York time on March 14, 2024 Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the “Company"), a developer, manufacturer and marke...

EYES - Recent Analysis Shows Abercrombie & Fitch, DaVita, W.W. Grainger, Ingredion, FirstEnergy, and Second Sight Medical Products Market Influences - Renewed Outlook, Key Drivers of Growth

NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Abercrombie & Fitch Company (NYSE:ANF), DaVita Inc. (NYSE:DVA), W....
EYES - Second Sight Medical Products, Inc. Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants (EYESW) Expiration Date

LOS ANGELES, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful v...

EYES - Second Sight Reports Fourth Quarter 2018 Business Update

-- Full Year 2018 net revenue estimated to be in the range of $6.5-$6.9 million -- -- 6 th Orion patient scheduled for implantation at Baylor Medical Center -- LOS ANGELES, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight&#x...

EYES - Second Sight Medical Products (EYES) CEO Will McGuire on Q3 2018 Results - Earnings Call Transcript

Second Sight Medical Products (EYES) Q3 2018 Earnings Conference Call November 7, 2018 04:30 PM ET Executives Lisa Wilson - IR Will McGuire - President and CEO John Blake - CFO Analysts Amit Dayal - H.C. Wainwright Presentation Operator Ladies and gentlemen, thank...
EYES - Second Sight Reports Third Quarter 2018 Financial Results

Encouraging Interim Results of Orion ® Feasibility Study with Four Subjects Cleared for Home Use LOS ANGELES, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufactur...

EYES - Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System

LOS ANGELES, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of use...

EYES - Second Sight to Discuss Third Quarter 2018 Financial Results on November 7, 2018 Conference Call

Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind individuals, will release its 2018 third quarter financial results on Wednesday, November 7, 2...
Previous 10 Next 10